Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pancreatic Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
This phase IB trial is studying how well giving gemcitabine together with Z650 works in treating patients with metastatic or recurrent pancreatic cancer.This phase IB trial is Multi-center and open?
This phase IB trial is studying how well giving gemcitabine together with Z650 works in treating patients with metastatic or recurrent pancreatic cancer.This phase IB trial is Multi-center and open?
Tracking Information
- NCT #
- NCT04131192
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: shu zhang Shandong Cancer Hospital Principal Investigator: lianke liu The First Affiliated Hospital with Nanjing Medical University
Get Well Soon